2m 2m 2m 2m 2m 2m 2m
NANOBIOTIX SP ADS (NBTX)
NASDAQ
$36.22-$0.38 (-1.04%)
Price as of Jun 23, 2026 6:48 PM EDT- $1.8BMarket Cap
- 697.96%1-Year Change
- BiotechnologyIndustry
NANOBIOTIX SP ADS (NBTX)
$36.22-$0.38 (-1.04%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 32.6M +553.25% | -7.2M -119.86% | 36.2M +658.10% | 4.8M +80.43% | |
Cost of Revenue | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Gross Profit | 32.6M +553.25% | -7.2M -119.86% | 36.2M +658.10% | 4.8M +80.43% | |
Sales and Marketing Expense | 20.4M -0.81% | 20.5M -6.90% | 22.0M +23.48% | 17.9M -8.11% | |
Research and Development Expense | -23.1M -42.98% | -40.5M +5.59% | -38.4M +17.65% | -32.6M +7.43% | |
Depreciation and Amortization Expense | 1.5M -7.77% | 1.6M +7.14% | 1.5M +0.87% | 1.5M -3.85% | |
Total Operating Expenses | 20.4M -0.81% | 20.5M -6.90% | 22.0M +23.48% | 17.9M -8.11% | |
Operating Profit | -10.8M -84.18% | -68.4M +155.39% | -26.8M -42.66% | -46.7M -11.18% | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Income and Expense and Net | 0 N/A | 0 N/A | 0 N/A | 0 N/A | |
Total Nonoperating Income and Expense | 3.0M -33.24% | 4.4M -28.15% | 6.2M +28.77% | 4.8M +81.11% | |
Income before Taxes | -24.0M -64.83% | -68.1M +71.62% | -39.7M -30.40% | -57.0M +21.36% | |
Income Taxes | 3,000 -97.03% | 101,000 -15.83% | 120,000 +1,100.00% | 10,000 +100.00% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -24.0M -64.83% | -68.1M +71.62% | -39.7M -30.40% | -57.0M +21.36% | |
Net Income from Continuing Operations Applicable to Common | -24.0M -64.83% | -68.1M +71.62% | -39.7M -30.40% | -57.0M +21.36% | |
Basic EPS and Net Income | -0.50 -65.28% | -1.44 +33.33% | -1.08 -34.15% | -1.64 +21.48% | |
Diluted EPS and Net Income | -0.50 -65.28% | -1.44 +33.33% | -1.08 -34.15% | -1.64 +21.48% | |
Basic Weighted Average Shares | 47.8B +1.17% | 47.3B +27.99% | 36.9B +5.96% | 34.9B +0.34% | |
Diluted Weighted Average Shares | 47.8B +1.17% | 47.3B +27.99% | 36.9B +5.96% | 34.9B +0.34% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 52.8M +6.06% | 49.7M -33.93% | 75.3M +81.90% | 41.4M -50.68% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 52.8M +6.06% | 49.7M -33.93% | 75.3M +81.90% | 41.4M -50.68% | |
Total Current Assets | 62.8M +2.09% | 61.5M -29.62% | 87.3M +66.81% | 52.4M -43.74% | |
Accumulated Depreciation | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Property and Plant and Equipment and Net | 4.6M -17.55% | 5.5M -11.41% | 6.3M -12.21% | 7.1M -13.02% | |
Total Long-Term Assets | 5.0M -15.81% | 6.0M -9.26% | 6.6M -11.52% | 7.4M -14.89% | |
Total Assets | 67.8M +0.51% | 67.4M -28.20% | 93.9M +57.10% | 59.8M -41.27% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 57.5M -2.42% | 58.9M +18.17% | 49.9M +31.47% | 37.9M +2.96% | |
Total Long-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Long-Term Liabilities | 94.7M +27.70% | 74.2M +61.75% | 45.9M -6.16% | 48.9M +28.17% | |
Total Liabilities | 152.2M +14.36% | 133.1M N/A | N/A N/A | N/A N/A | |
Retained Earnings | -400.8M +5.36% | -380.4M +20.19% | -316.5M +39.24% | -227.3M N/A | |
Total Stockholders Equity | -84.5M +28.58% | -65.7M +3,465.06% | -1.8M -93.19% | -27.0M -200.95% | |
Total Shares Outstanding | 48.4M +2.07% | 47.4M +0.62% | 47.1M +35.06% | 34.9M +0.16% | |
Cash Flow | |||||
Cash from Operating Activities | -33.4M +70.95% | -19.6M +56.71% | -12.5M -66.38% | -37.1M +24.21% | |
Capital Expenditures | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Investing Activities | -578,000 -39.48% | -955,000 +173.64% | -349,000 -352.90% | 138,000 +157.02% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 37.4M +828.65% | -5.1M -110.98% | 46.8M +927.66% | -5.7M +9.09% | |
Financials Ratio | |||||
Gross Margin | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Operating Margin | -33.19% -103.49% | 951.08% +1,385.92% | -73.96% -92.44% | -977.85% -50.77% | |
Return on Assets | -35.45% -58.03% | -84.47% +63.48% | -51.67% -26.84% | -70.62% +77.15% | |
Return on Equity | 31.91% -84.18% | 201.73% -26.60% | 274.85% -99.39% | 44,738.04% +46,385.69% | |
Revenue Growth | 553.25% +561.57% | -119.86% -118.21% | 658.10% +718.22% | 80.43% +1,396.61% | |
Current Ratio | 1.09 +4.63% | 1.04 -40.45% | 1.75 +26.88% | 1.38 -45.35% | |
Cash Ratio | 0.92 +8.70% | 0.84 -44.09% | 1.51 +38.36% | 1.09 -52.10% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow